Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

mycobacteria; tuberculosis; multi-drug resistance; drug discovery; promiscuous targets; Mycobacterium tuberculosis; rifampin; isoniazid; mechanisms of resistance; mutations; granulomas; caseum; cell envelope; dormancy; delpazolid; macozinone; DprE1 inhibitor; clinical studies; discovery; mode of action; drug resistance; toxicity; target; energy metabolism; electron transport chain; oxidative phosphorylation; bedaquiline; Q203; MID3; pharmacokinetics; pharmacodynamics; drug-drug interactions; in vitro; in vivo; drug development; tuberculosis treatment; biomarkers; drug combination; clinical trial; BCG; tuberculosis vaccines; TBVI; EDCTP; IAVI; CTVD; host-directed therapy; anti-virulence compounds; TB; post-treatment sequelae; surgery; pulmonary rehabilitation; Carlo Forlanini; artificial pneumothorax; n/a; structure-based drug design; target-based drug design; PknB; PknG; DNA gyrase; antibiotic; mycobacterium; genomics; transcriptomics; proteomics; metabolomics; lipidomics; target identification; mechanism of action; antimicrobial drug resistance (AMR); target-based screening; phenotypic screening; antituberculosis agents; antimycobacterial; anti-TB drug pipeline; privileged targets; lead generation